Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel small molecule inhibitor of GPR68 attenuates endothelial dysfunction and lung injury caused by bacterial lipopolysaccharide.

Scientific reports·2025
Same author

Biodistribution of a Mucin 4-Selective Monoclonal Antibody: Defining a Potential Therapeutic Agent Against Pancreatic Cancer.

International journal of molecular sciences·2025
Same author

Inhibition of proton sensor GPR68 suppresses endothelial dysfunction and acute lung injury caused by Staphylococcus aureus bacterial particles.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2025
Same author

KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma.

Nature communications·2024
Same author

Amphipathic Helical Peptide L37pA Protects against Lung Vascular Endothelial Dysfunction Caused by Truncated Oxidized Phospholipids via Antagonism with CD36 Receptor.

American journal of respiratory cell and molecular biology·2023
Same author

Aging-Related Accumulation of Truncated Oxidized Phospholipids Augments Infectious Lung Injury and Endothelial Dysfunction via Cluster of Differentiation 36-Dependent Mechanism.

Cells·2023

Related Experiment Video

Updated: Apr 28, 2026

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

1.9K

Structure-Activity Studies on Antiproliferative Factor (APF) Glycooctapeptide Derivatives.

Piotr Kaczmarek1, Gillian M Tocci2, Susan K Keay3

  • 1Chemical Biology Laboratory, Molecular Discovery Program.

ACS Medicinal Chemistry Letters
|June 6, 2014
PubMed
Summary

Antiproliferative factor (APF) analogues were studied for their effect on bladder epithelial cell proliferation. The simplest potent analogue, derivative 9, retains antiproliferative activity by replacing a trivaline tail with alanines.

Keywords:
Interstitial cystitis/painful bladder syndromeantiproliferativeglycopeptidehydrophobicitypeptide conformation

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.5K
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

592

Related Experiment Videos

Last Updated: Apr 28, 2026

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use
10:33

An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use

Published on: May 24, 2024

1.9K
Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

11.5K
A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

592

Area of Science:

  • Biochemistry
  • Cell Biology
  • Urology

Background:

  • Antiproliferative factor (APF) is a glycopeptide linked to interstitial cystitis/painful bladder syndrome (IC/PBS).
  • Previous studies showed that unsialylated APF (as-APF) and its truncated form (as-APF8) inhibit bladder epithelial cell proliferation.
  • Understanding the structure-activity relationship of as-APF is crucial for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the structural basis for the sustained antiproliferative activity of the truncated eight amino acid as-APF (as-APF8).
  • To synthesize and evaluate amino acid-substituted derivatives of as-APF8 for their ability to inhibit bladder epithelial cell proliferation.
  • To determine the solution conformations of these derivatives using biophysical techniques.

Main Methods:

  • Synthesis of as-APF8 derivatives with specific amino acid substitutions.
  • In vitro assays to measure the inhibition of bladder epithelial cell proliferation.
  • Circular Dichroism (CD) and Nuclear Magnetic Resonance (NMR) spectroscopy to analyze solution conformations.

Main Results:

  • Single amino acid substitutions in as-APF8 generally reduced antiproliferative activity.
  • Replacing the trivaline tail with three alanines (derivative 9) fully maintained antiproliferative potency.
  • Derivative 9 represents the simplest, fully potent APF analogue synthesized to date.

Conclusions:

  • The trivaline tail of as-APF8 is not essential for maintaining antiproliferative activity.
  • Derivative 9, a simplified analogue, is a promising candidate for further investigation in IC/PBS.
  • Structural modifications can yield potent APF analogues with potential therapeutic applications.